The Claim
Microcystin-LR inhibits protein phosphatase 2A (PP2A) in mouse liver tissue, resulting in sustained activation of JNK and downstream activation of inflammatory and insulin resistance pathways.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Microcystin-LR blocks protein phosphatase 2A in mouse liver, which leads to prolonged activation of JNK and the activation of pathways that promote inflammation and insulin resistance.
See the scientific wording
Microcystin-LR inhibits protein phosphatase 2A (PP2A) in mouse liver tissue, leading to sustained activation of JNK and downstream inflammatory and insulin resistance pathways.
Microcystin-LR blocks a liver enzyme that normally turns off a stress signal called JNK. Without this brake, JNK stays active and directly interferes with insulin signaling by modifying a key protein, while also turning on inflammation by activating another pathway that releases immune chemicals. This causes the liver to resist insulin and become inflamed.
What the research says
1 studyMicrocystin-LR messes up a natural brake (PP2A) in liver cells, causing a stress signal (JNK) to stay on too long, which leads to inflammation and makes the body less able to use insulin properly. The study proved this chain happens in mice.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.